ResearcherMayo ClinicActive in the last 2 years
Victor E. Velculescu
Matched on ORCID iD 0000-0003-1195-438X; OpenAlex author ID A5006560755. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 55
2012: 3 papers · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 7
- Genome-wide analyses of cell-free DNA for therapeutic monitoring of patients with pancreatic cancer. Last author DOI 10.1126/sciadv.ads5002↗
- Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-19-0197↗
- Clinical study of genomic drivers in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/bjc.2017.209↗
- Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. Last author DOI 10.1038/ncomms8686↗
- Rapid characterization of candidate biomarkers for pancreatic cancer using cell microarrays (CMAs). Co-author DOI 10.1021/pr300483r↗
- Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors. Co-author DOI 10.1158/1078-0432.ccr-12-1215↗
- ATM mutations in patients with hereditary pancreatic cancer. Co-author DOI 10.1158/2159-8290.cd-11-0194↗
Closest collaborators
The 25 strongest of 55 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Carolyn Hruban · 2 shared papers, 2015–2025 · strength 0.23
- Julia Sidenius Johansen · 2 shared papers, 2015–2025 · strength 0.23
- Susann Theile · 1 shared paper, 2025 · strength 0.20
- Inna Markovna Chen · 1 shared paper, 2025 · strength 0.20
- Ralph H. Hruban MD · 5 shared papers, 2012–2019 · strength 0.17
- Paper Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-19-0197↗
- Paper Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. DOI 10.1038/ncomms8686↗
- Paper Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential lo… DOI 10.1158/1078-0432.ccr-12-1215↗
- James R. Eshleman · 3 shared papers, 2012–2019 · strength 0.12
- Paper Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-19-0197↗
- Paper Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. DOI 10.1038/ncomms8686↗
- Paper ATM mutations in patients with hereditary pancreatic cancer. DOI 10.1158/2159-8290.cd-11-0194↗
- Michael Goggins · 3 shared papers, 2012–2019 · strength 0.11
- Paper Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-19-0197↗
- Paper Rapid characterization of candidate biomarkers for pancreatic cancer using cell microarrays (CMAs). DOI 10.1021/pr300483r↗
- Paper ATM mutations in patients with hereditary pancreatic cancer. DOI 10.1158/2159-8290.cd-11-0194↗
- Peter James O'Dwyer · 2 shared papers, 2015–2017 · strength 0.09
- Mark Sausen · 2 shared papers, 2015–2017 · strength 0.09
- Jeffrey A. Drebin · 2 shared papers, 2015–2017 · strength 0.09
- Daniel D. Von Hoff · 2 shared papers, 2015–2017 · strength 0.09
- Michael T. Barrett · 2 shared papers, 2015–2017 · strength 0.09
- Christopher Lee Wolfgang · 2 shared papers, 2012–2019 · strength 0.09
- Daniel A. Laheru · 2 shared papers, 2012–2019 · strength 0.09
- Jun Yu · 2 shared papers, 2012–2019 · strength 0.09
- Alina Hasanain · 1 shared paper, 2019 · strength 0.07
- Ding Ding · 1 shared paper, 2019 · strength 0.07
- Jin Peng He · 1 shared paper, 2019 · strength 0.07
- Georgios Gemenetzis · 1 shared paper, 2019 · strength 0.07
- Izaak Quintus Molenaar · 1 shared paper, 2019 · strength 0.07
- Richard Andrew Burkhart · 1 shared paper, 2019 · strength 0.07
- Matthew John Weiss · 1 shared paper, 2019 · strength 0.07
- Lei Zheng · 1 shared paper, 2019 · strength 0.07
- Vincent P. Groot · 1 shared paper, 2019 · strength 0.07
- Amol Kumar Narang · 1 shared paper, 2019 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.